Rex Hoffman, M.D., MBA, says physician shortages and burnout are the most underestimated pressures on health system.
News|Articles|January 2, 2026
Top 5 skin cancer articles of 2025
Author(s)MHE Staff
Listen
0:00 / 0:00
Key Takeaways
- Blood or marrow transplant recipients face higher skin cancer risk due to monoclonal antibody treatment, chronic graft-versus-host disease, and post-transplant immunosuppression.
- AI shows potential in skin cancer detection, but requires further clinical validation, particularly for diverse skin tones.
The top news to come out of skin cancer coverage this year for MHE focused on blood or marrow transplant recipients experiencing increased skin cancer risk, highlighting the need for vigilant monitoring and innovative treatment strategies.
Advertisement
- Blood or Marrow Transplant Recipients Face Higher Skin Cancer Risk, Study Shows
Risk factors for secondary skin cancer after blood or marrow transplant include those who had treatment with a monoclonal antibody, chronic graft-versus-host disease and post-transplant immunosuppression.Read more - AI Shows Promise in Skin Cancer Detection, But Clinical Validation Still Needed
Few studies in this analysis assessed the accuracy of AI in detecting melanoma in diverse skin tones.Read more
- Protein Responsible for Parkinson’s Disease Also Drives Melanoma Progression
A new study suggests that targeting the protein alpha-synuclein could be a possible new target for treating melanoma.Read more - New Alpha Radiation Therapy Shows Promise for Hard-to-Treat Melanoma
Researchers said alpha particles are promising therapies that target cancer while minimizing the damage to nearby healthy tissues.Read more - Early Trial of Libtayo Combination Demonstrates Activity in Melanoma
Fianlimab plus Libtayo demonstrated persistent and significant clinical activity in patients with advanced melanoma.Read more
Advertisement
Related to this article
Rex Hoffman, M.D., MBA, of Providence Holy Cross walks through a CMO’s day in a hospital that often runs 85% to 100% full, from safety huddles to discharges.
On average, caregivers want to see their children with ADHD fall asleep 30 minutes faster, but the best sleep treatments average approximately 20 minutes, a new survey study found.
Research findings presented at CHEST meeting show COPD hospital readmission drops with discharge checklists and navigation. Other research suggests targeting readmission prevention efforts on patents discharged to post-acute facilities.
As the pharmacist pipeline tightens, leaders from UC Davis Health, UCSF Health, and Sutter Health say financial sustainability now depends as much on capacity as on cost.
GLP-1 use in adults 65 and older with MASLD was linked to a 45% lower risk of death, and a 28% lower risk of hepatic decompensation, a new Houston Methodist Research Institute study shows.
New data from Sutter Health suggest the real gap in GLP-1 access is physician awareness, not insurance coverage — and fixing it closed outcome disparities across every racial and ethnic group.
Research findings presented at the CHEST meeting show that false positives may make patients more adherent to screening. Qualitative research shows that patients want more explanation and results communicated verbally.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
GLP-1 therapy tied to lower mortality and liver decompensation in older adults with MASLD
2
Kaiser’s formulary chief makes his case for a ‘total value’ model on biologics | HSES 2026
3
Health-system pharmacy leaders are being asked to solve a margin problem and it is costing hospitals | HSES 2026
4
The GLP-1 access gap in type 2 diabetes isn’t coverage — it’s physician awareness | HSES 2026
5